, Tracking Stock Market Picks
Enter Symbol:
Immunogen, Inc. (IMGN) [hlAlert]

up 63.76 %

Immunogen, Inc. (IMGN) rated Outperform with price target $11 by Oppenheimer

Posted on: Friday,  Feb 6, 2015  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Immunogen, Inc. (NASDAQ: IMGN) on 02/06/2015. Previously Oppenheimer rated Outperform Immunogen, Inc. (NASDAQ: IMGN) on 07/07/2009., when
the stock price was $8.72. Since then, Immunogen, Inc. has gained 63.76% as of 01/08/2016's recent price of $14.28.
If you would have followed the previous Oppenheimer's recommendation on IMGN, you would have gained 63.76% of your investment in 2376 days.

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/6/2015 8:25 AM Buy
7.74 11.00
as of 8/27/2015
1 Week down  -4.67 %
1 Month down  -5.61 %
3 Months up  67.01 %
1 YTD down  -2.65 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2013 8:25 AM Buy
14.54 28.00
7/7/2009 8:25 AM Buy
8.72 12.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy